Pooled Complement Human Serum - May 31, 2017

Posted by Leanne Kodsman on

May 31, 2017 Innovative Research's Pooled Complement Human Serum was recently used in the following study:

Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica

L Tradtrantip, X Yao, T Su, AJ Smith, AS Verkman - Acta Neuropathologica, 2017 ... Complement dependent cytotoxicity Specified concentrations of AQP4-IgG (or control human IgG, Thermo Fisher Scientific, Rockford, IL) and human complement (Innovative Research, Novi, MI) were added in Hank's buffer, and cells were incubated at 37 C for specified times. ...

  • Tags: Human Serum, Pooled Human Complement Serum

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study
    Human Plasma from Innovative Research was used in the following study:   HIV Integrase...
    Read the Article
    Two-level submicron high porosity membranes (2LHPM) for the capture and release of white blood cells (WBCs)
    Single Donor Human Whole Blood from Innovative Research was used in the following study...
    Read the Article
    Ultrasensitive multi-species detection of CRISPR-Cas9 by a portable centrifugal microfluidic platform
    Human Whole Blood, Pooled Human Serum, and Pooled Human Plasma from Innovative Research...
    Read the Article

    ← Older Post Newer Post →